Quentin Chalret du Rieu

Statistics

Publications

Citations

H-Index

Active since

2013

Affiliations

Université Toulouse III - Paul Sabatier(Current)

Servier (France)

Institut Claudius Regaud

Institut des Hautes Études Scientifiques

Quentin Chalret du Rieu is an author at Université Toulouse III - Paul Sabatier specializing in pharmacology, pharmacokinetics, and enzyme inhibition.

Publications per year

2013–2014

Publications

Population pharmacokinetics of peritoneal, plasma ultrafiltrated and protein-bound oxaliplatin concentrations in patients with disseminated peritoneal cancer after intraperitoneal hyperthermic chemoperfusion of oxaliplatin following cytoreductive surgery: correlation between oxaliplatin exposure and thrombocytopenia

Quentin Chalret du Rieu, Mélanie White‐Koning, Laetitia Picaud et al. · Cancer Chemotherapy and Pharmacology · 2014 · 37 citations

Medicine, Oncology, Pharmacokinetics +13

Pharmacokinetic/pharmacodynamic modelling-based optimisation of administration schedule for the histone deacetylase inhibitor abexinostat (S78454/PCI-24781) in phase I

Sylvain Fouliard, Renata Robert, Anne Jacquet-Bescond et al. · European Journal of Cancer · 2013 · 33 citations

Pharmacy, Pharmacokinetics, Pharmacology +16

Pharmacokinetic/Pharmacodynamic modeling of abexinostat-induced thrombocytopenia across different patient populations: application for the determination of the maximum tolerated doses in both lymphoma and solid tumour patients

Quentin Chalret du Rieu, Sylvain Fouliard, Mélanie White‐Koning et al. · Investigational New Drugs · 2014 · 14 citations

Pharmacy, Pharmacokinetics, Pharmacology +17

Application of Hematological Toxicity Modeling in Clinical Development of Abexinostat (S-78454, PCI-24781), A New Histone Deacetylase Inhibitor

Quentin Chalret du Rieu, Sylvain Fouliard, Anne Jacquet-Bescond et al. · Pharmaceutical Research · 2013 · 10 citations

Medicine, Hematology, Pharmacology +15

1–4 of 4